Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pact
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
- Latest
- Trending
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
Analysts predict AI-integrated iPhones could boost Apple's stock and sales, potentially leading to more device replacements and revenue opportunities.
Hasbro is set to release its Q4 results, with a predicted profit increase but a 20% decline in revenue. Analysts ...
Canadian cannabis producer Organigram Holdings Inc. has made its first shipment of bulk dried flower to Sanity Group, entering the ...
Loop Capital downgrades FMC Corp. to Hold and lowers price target due to inventory challenges in critical markets. Concerns over ...
Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
Investment company Investcorp plans to list a portfolio company in the Gulf region by 2024, with optimism for completion in ...
Learn how to maximize the value of your employee stock options (ESOs) with strategies, tips, and long-term planning. A comprehensive ...
The S&P 500 has reached a historic milestone, surpassing 5000 points for the first time and doubling since the pandemic ...
TD Cowen increases price target for HCA Holdings, expects strong performance & market share growth. Positive outlook for the healthcare ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.